ARKEMA S/ADR - ARKAY STOCK NEWS

Arkema reported a strong Q3 2021, with Group EBITDA increasing by 54.4% year-on-year, reaching €474 million.

Sales rose 25.6% to €2.4 billion, bolstered by a focus on Specialty Materials. The adjusted net income surged to €258 million, or €3.44 per share. Specialty Materials accounted for 87.5% of total sales, with EBITDA up 57.1% to €421 million. Despite raw material shortages, demand for sustainable solutions accelerated. Arkema has raised its full-year EBITDA guidance to approximately €1.6 billion, reflecting confidence in continued growth.

Arkema has announced a series of share buyback transactions from November 1 to November 5, 2021, as part of its ongoing financial strategy. A total of 144,930 shares were repurchased at a weighted average price of €117.05. The buybacks occurred under Regulation (EU) No 596/2014, indicating Arkema's commitment to enhancing shareholder value. This move reflects the company's robust financial position and strategic initiatives to optimize its capital structure.

Arkema has announced its share buyback transactions conducted from October 25 to October 29, 2021, as per EU regulations. A total of 57,046 shares were repurchased at a weighted average price of €118.4760. The specific volumes and prices for each day of the transactions are detailed, highlighting significant daily buybacks. These moves reflect Arkema's strategy to enhance shareholder value and respond to market conditions.

Arkema has announced share buyback transactions conducted between October 11 and October 15, 2021. The total of 24,788 shares was repurchased at an average price of €110.1474. The breakdown includes 10,000 shares on October 11 with a weighted average price of €110.2738, followed by further purchases on October 12 totaling 14,788 shares at lower average prices. This buyback program is part of Arkema's strategy to enhance shareholder value, providing a signal of confidence in the company's financial health.

Arkema has reported share buyback transactions executed from October 4 to October 8, 2021, under the European Regulation No. 596/2014. The total volume of shares bought back is 207,646, with a weighted average price of 110.7453 per share. Notable transactions include on October 6, where 38,180 shares were purchased at an average price of 109.1182. Detailed information is available on Arkema's investor relations page.

Arkema has announced plans to construct a new polyamide 11 powders plant in Changshu, China, set to begin operations in Q1 2023. This facility supports a 50% increase in global bio-based polyamide 11 production capacity, aligning with rising demand in Asia. The polyamide 11 powders, made from renewable castor beans, are known for their durability and versatility, catering to industries like aerospace and additive manufacturing. This expansion complements a larger project in Singapore, part of a €450 million investment in Asia.

On September 30, 2021, Arkema reported a total of 76,736,476 shares outstanding. The total number of voting rights, including shares held by the company, was 87,353,662. Excluding shares held by the company, the total voting rights were 85,031,332. This report provides essential shareholder data necessary for understanding the company's market position.

Arkema has announced its recent share buyback transactions conducted from September 27 to October 1, 2021. A total of 118,035 shares were repurchased at an average price of €113.95. The transactions were executed in accordance with Regulation (EU) No 596/2014. Specific details include daily volumes and prices across multiple trading days. The buyback aims to enhance shareholder value and demonstrates Arkema's commitment to returning capital to its investors.

Arkema has reported share buyback transactions from September 20 to September 24, 2021, in compliance with EU regulations. During this period, the company repurchased a total of 104,175 shares at a weighted average price of €111.4604. Notable transactions include the purchase of 10,000 shares on September 24 at €114.7257. Detailed information is available on Arkema's investor relations page.